Understanding how a specific process regulates gene expression in cells
Mechanism and Regulation of U1 snRNP Telescripting
['FUNDING_OTHER'] · UNIVERSITY OF PENNSYLVANIA · NIH-11077758
This study is looking at a new process that helps make sure our genes are copied correctly, which is important for keeping our cells healthy, and it could help us understand how problems with this process might lead to diseases like cancer, ultimately helping patients get better treatments.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-11077758 on ClinicalTrials.gov |
What this research studies
This research investigates a newly identified process called telescripting, which is essential for the proper transcription of protein-coding genes. It focuses on how U1 snRNP, a critical RNA-protein complex, prevents premature termination of messenger RNA (mRNA) synthesis, ensuring that mRNAs are fully formed and functional. By studying the molecular mechanisms involved, the research aims to uncover how changes in this process can affect gene expression and potentially lead to various diseases, including cancers. Patients may benefit from insights gained about gene regulation and its implications for treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions related to gene expression dysregulation, such as certain cancers.
Not a fit: Patients with conditions unrelated to gene expression or those not affected by the mechanisms being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for manipulating gene expression, which may improve treatments for various diseases, including cancer.
How similar studies have performed: While the specific process of telescripting is novel, related research on gene expression regulation has shown promising results in understanding and treating various diseases.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DREYFUSS, GIDEON — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: DREYFUSS, GIDEON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.